Topic: Pharmaceuticals Sector

Special Report: Outgunned FDA tries to get tough with drug ads

SILVER SPRING, Maryland (Reuters) - It wasn't what you would call a casual get-together. In February 2009, a popular New York blogger attended a brunch with fellow "frazzled moms." They took in tips from a style expert and listened to a nurse ...
PFE has done nothing but go downDon't people buy stocks because they think the stocks will go up in value? Well not Pfizer (NYSE: PFE) shareholders. If you're a Pfizer shareholder, maybe you need the company to develop a drug that makes ...

Ex-hedge fund manager charged with insider trading

NEW YORK (Reuters) - A former hedge fund manager has been accused by a U.S. regulator of illegal insider trading in MedImmune Inc securities prior to the acquisition of the pharmaceutical company by Britain's AstraZeneca Plc. In a lawsuit filed Wednesday in ...

Astra's Brilinta wins early backing in guidelines

STOCKHOLM (Reuters) - AstraZeneca's new blood-thinning drug Brilinta has been given a class 1 recommendation as a treatment option under European medical guidelines, even though it has yet to be approved for sale. New European Society of Cardiology guidelines include the medicine, ...
NAME: William C. Weldon AGE: 61 EDUCATION: Quinnipiac University, bachelor's degree. PERSONAL: Married, two children, one grandson. PROFESSIONAL EXPERIENCE: Johnson & Johnson Chairman and CEO since April 2002. Previously served as: worldwide head of J&J's pharmaceuticals division, since 1998; chairman of Ethicon ...

FDA releases latest list of safety issues

WASHINGTON (Reuters) - The U.S. Food and Drug Administration has released its latest list of possible drug safety concerns, citing Roche's breast cancer drug Herceptin and Sanofi Aventis' heart drug Multaq, among others. The list, which comes out quarterly, covers safety issues ...
Novartis completes $38.7 billion purchase of Nestle's stake in eye care firm AlconSwiss pharmaceutical company Novartis AG says it has completed its purchase of Nestle SA's 77 percent stake in eye care firm Alcon Inc. at a total cost of $38.7 billion. ...

Corrected -Glaxo starts final clinical trial of shingles vaccine

Corrects name of virus in 5th paragraph. LONDON (Reuters) - British pharmaceutical giant GlaxoSmithKline said on Monday it had started final trials of its new vaccine to prevent shingles, one of the most significant products in its pipeline. More than 30,000 patients ...
Shire PLC said Tuesday it will pull a blood-pressure drug off the market following warnings from federal regulators who said the drug has not been proven effective. The Irish drugmaker said in a statement it will withdraw ProAmatine by the end of ...
Summary Box: Eli Lilly halts development of potential Alzheimer's drug in late-stage testingDRUG DEVELOPMENT HALTED: Indianapolis drugmaker Eli Lilly and Co. said Tuesday it stopped developing the potential Alzheimer's disease treatment semagacestat when late-stage studies showed it did not slow the disease, ...
Previous